OREANDA-NEWS. George Heidgerken, Head of Boehringer Ingelheim Animal Health said: “Ingelvac CircoFLEX® is the first PCV2 vaccine licensed in the European Union to protect piglets as well as sows. We are proud that we can now offer veterinarians and farmers the means for an even broader protection of pig herds against this fatal virus.”

PCV2 can have a devastating impact on the pigs’ health, causing suffering to the animals and economic damage to the farmers. An infection with this virus may lead to wasting, paleness of the skin, dyspnea or diarrhea in piglets. In breeding herds, PCV2 infection can cause reproductive losses in sows. In both, piglets and sows, PCV2 can also cause medically and economically relevant subclinical infections (infections without evident clinical signs).
It has been demonstrated in further studies that sow vaccination with Ingelvac CircoFLEX® has significant positive effects on the reproductive performance, in particular the farrowing rate, the number of piglets born alive and weaned per litter.2,3,4,5,6

Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.

In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 19.9 per cent of its net sales.